Free US stock cash flow analysis and free cash flow yield calculations to identify companies returning value to shareholders through dividends and buybacks. Our cash flow research helps you find companies with the financial flexibility to grow their business and return capital to investors. We provide cash flow statements, free cash flow yields, and dividend sustainability analysis for comprehensive coverage. Find cash-generating companies with our comprehensive cash flow analysis and yield calculation tools for income investing.
On April 27, 2026, Johnson & Johnson (NYSE: JNJ) announced the U.S. FDA granted Priority Review for its supplemental Biologics License Application (sBLA) for IMAAVY® (nipocalimab-aahu) for the treatment of warm autoimmune hemolytic anemia (wAIHA), a rare life-threatening condition with no currently
Johnson & Johnson (JNJ) Secures FDA Priority Review for IMAAVY, Targeting First-of-Its-Kind Indication for Warm Autoimmune Hemolytic Anemia - Intrinsic Value
JNJ - Stock Analysis
4519 Comments
946 Likes
1
Ritamarie
Returning User
2 hours ago
Free US stock insider buying and selling tracking with regulatory filing analysis for inside information on company health and management confidence. We monitor corporate insider transactions because company officers often have the best understanding of their business prospects and future outlook. We provide 13D filings, insider buying and selling data, and trend analysis for comprehensive coverage. Get inside information with our comprehensive insider tracking and analysis tools for informed investment decisions.
👍 99
Reply
2
Kailib
New Visitor
5 hours ago
Indices are consolidating after recent gains, offering tactical entry points.
👍 93
Reply
3
Antoria
Community Member
1 day ago
This is the kind of thing you only see too late.
👍 219
Reply
4
Qari
Insight Reader
1 day ago
I read this like I had a deadline.
👍 66
Reply
5
Vincie
Community Member
2 days ago
I don’t know what this is, but it matters.
👍 66
Reply
© 2026 Market Analysis. All data is for informational purposes only.